Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Evaluation of social, cultural and behavioral factors
International Peace Maternity and Child Health Hospital
Cardio-vascular Disease
1 trial -
Ferrous Fumarate Oral Tablet
Hospital Authority, Hong Kong
Iron Deficiency Anemia Treatment
1 trial -
Metoclopramide 10mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Cancer
1 trial -
Modafinil Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
Oral Chondroitin Sulfate (Flextrum)
COLLEGIUM PHARMACEUTICAL, INC
Meniscus Lesion
1 trial -
Oral Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
2 trials -
Oral Stimulant Drink
Cardiff Oncology
Volatile Organic Compounds
1 trial -
Oral carbohydrate (Outfast)
The First People's Hospital of Lianyungang
Gastrointestinal Surgery
1 trial -
Oral fluid
Hospital Authority, Hong Kong
Osteoarthritis, Knee
1 trial -
Oral microbiota
Hospital Authority, Hong Kong
Dry Eye Syndrome
1 trial -
Oral nutritional supplementation (ONS)
United Therapeutics Europe Ltd
Muscle Wasting
1 trial -
Oral supplementation of vitamin D
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
Paclitaxel Oral Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-Small-Cell Lung Cancer
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
The First People's Hospital of Lianyungang
Breast Cancers
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancers
1 trial -
Postoperative radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Tongue Squamous Cell Carcinoma
1 trial -
Ropivacaine
Hospital Authority, Hong Kong
Femoral Fracture
1 trial -
Venclexta 100 MG Oral Tablet
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Yinxingmihuan oral solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Stable Angina
1 trial -
carotid-femoral pulse-wave velocity
Structure Therapeutics
Covid19
1 trial -
high caloric oral nutritional supplements
The First People's Hospital of Lianyungang
Malnutrition, Child
1 trial -
oral nutritional supplement
Hospital Authority, Hong Kong
Gastric Cancer
1 trial -
preoperative oral carbohydrate drink
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources